Evidence map›Paper›PMID 35476102›Full record

ArticleRevista de saude publica2022

Systemic autoimmune diseases and work outcomes in Brazil: a scoping review.

Rafael Alves Cordeiro, Frida Marina Fischer, Samuel Katsuyuki Shinjo

Open access · goldAbstract readScoping Review
In one paragraph

Article in Revista de saude publica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rafael Alves CordeiroUniversidade de Sao Paulo. Faculdade de Medicina. Departamento de Reumatologia. São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-5695-9136
Frida Marina FischerUniversidade de Sao Paulo. Faculdade de Saude Publica. Departamento de Saude Ambiental. São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0001-9403-6300
Samuel Katsuyuki ShinjoUniversidade de Sao Paulo. Faculdade de Medicina. Departamento de Reumatologia. São Paulo, SP, Brasil.ORCID http://orcid.org/0000-0002-3682-4517
Universidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo review articles that assessed work-related outcomes such as workability, work productivity, presenteeism, absenteeism, sick leave, return to work, and employment status of Brazilian patients with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome, and systemic autoimmune myopathies.

methodsThis study was conducted in Medline databases (PubMed), SciELO, and Lilacs through a combination of descriptors of interest. Studies published until December 2020 were considered in the search strategy.

resultsEight out of 90 articles met the eligibility criteria and were included in this review. The studies are highly heterogeneous. Most of them are cross-sectional, and all of them address rheumatoid arthritis or systemic lupus erythematosus. A common denominator among these studies is the high proportion of patients outside the labor market.

conclusionsIn general, the studies show unfavorable labor outcomes and impaired participation in the Brazilian workforce among the samples of patients assessed. There is a need to better understand several topics about Brazilian patients with systemic autoimmune diseases and their work context, as well as to conduct studies focusing on rarer diseases and on the themes of return and reintegration to work.

Indexed as

Arthritis, RheumatoidAutoimmune DiseasesLupus Erythematosus, SystemicBrazilCross-Sectional StudiesHumans

Identifiers

PMID35476102
PMCPMC9004705
OpenAlexW4225893050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.